Stocklytics Platform
Asset logo for symbol TNGX
Tango Therapeutics
TNGX58
$9.16arrow_drop_down15.88%-$1.73
Asset logo for symbol TNGX
TNGX58

$9.16

arrow_drop_down15.88%

Income Statement (TNGX)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT-$29.55M-$42.25M-$35.01M-$25.62M-$23.36M
EBITDA-$28.92M-$41.63M-$34.39M-$25.01M-$23.24M
gross Profit$19.24M$5.84M$4.81M$10.11M$13.09M
NET Income-$25.55M-$37.91M-$30.76M-$22.26M-$20.71M
total Revenue$19.87M$6.47M$5.43M$10.73M$14.59M

Balance Sheet (TNGX)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt-$13.72M-$22.92M-$27.46M-$19.02M-$26.16M
stockholders Equity$247.67M$264.45M$253.10M$276.59M$212.94M
total Assets$381.45M$406.22M$402.56M$428.18M$379.32M
total Debt$37.83M$38.23M$38.92M$39.50M$39.88M
total Liabilities$133.78M$141.77M$149.45M$151.59M$166.38M

Cash Flow (TNGX)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow$1.31M$42.98M$1.46M$80.28M$586.00K
free Cash Flow-$23.92M-$38.05M-$27.69M-$31.15M-$25.13M
investing Cash Flow-----
operating Cash Flow-$23.60M-$37.85M-$27.46M-$31.13M-$24.47M

Tango Therapeutics (TNGX) Financials

The income statement of Tango Therapeutics, Inc. (TNGX) provides a comprehensive overview of the company's financial performance. It shows the revenue generated by the company, as well as the expenses incurred during a specific period. The net income from stockholders represents the profit earned by the company after deducting all expenses and taxes. This is an important metric that indicates the overall profitability of the company. EBIT and EBITDA are also crucial financial indicators that measure the company's operating performance. EBIT stands for Earnings Before Interest and Taxes, while EBITDA represents Earnings Before Interest, Taxes, Depreciation, and Amortization. These metrics help evaluate a company's profitability before accounting for interest, taxes, and non-cash expenses. Gross profit refers to the revenue remaining after deducting the cost of goods sold. It is an essential indicator of the company's ability to generate profit from its core operations.
The balance sheet of Tango Therapeutics, Inc. (TNGX) provides a snapshot of the company's financial position at a specific point in time. It includes the company's total assets, total liabilities, and stockholders' equity. Total assets represent the company's resources, including cash, investments, property, and equipment. Total liabilities include the company's debts and other obligations. Stockholders' equity is the residual interest in the company's assets after deducting liabilities. It represents the ownership interest of the company's shareholders. Cash equivalents are highly liquid assets that can be readily converted into cash. These include short-term investments with original maturities of three months or less. Net debt is calculated by subtracting a company's cash and cash equivalents from its total debt. It provides an indication of the company's ability to meet its financial obligations. The cash flow statement of Tango Therapeutics, Inc. (TNGX) shows the cash generated and used by the company during a specific period. It includes operating cash flow, investing cash flow, and financing cash flow. Operating cash flow represents the cash generated from the company's core operations, excluding investments and financing activities. Investing cash flow includes the cash used for acquiring or disposing of assets. Financing cash flow includes the cash from or used for borrowing, repaying debt, or issuing and repurchasing equity. Free cash flow is the cash available to the company after deducting capital expenditures necessary to maintain or expand its asset base. It is a crucial indicator of the company's financial health.
add Tango Therapeutics to watchlist

Keep an eye on Tango Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media